Open Access

[Corrigendum] Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway

  • Authors:
    • Zhuo Li
    • Dehai Yu
    • Haijun Li
    • You Lv
    • Sijie Li
  • View Affiliations

  • Published online on: January 10, 2024     https://doi.org/10.3892/ijo.2024.5611
  • Article Number: 23
  • Copyright : © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

March-2024
Volume 64 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li Z, Yu D, Li H, Lv Y and Li S: [Corrigendum] Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway. Int J Oncol 64: 23, 2024.
APA
Li, Z., Yu, D., Li, H., Lv, Y., & Li, S. (2024). [Corrigendum] Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway. International Journal of Oncology, 64, 23. https://doi.org/10.3892/ijo.2024.5611
MLA
Li, Z., Yu, D., Li, H., Lv, Y., Li, S."[Corrigendum] Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway". International Journal of Oncology 64.3 (2024): 23.
Chicago
Li, Z., Yu, D., Li, H., Lv, Y., Li, S."[Corrigendum] Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway". International Journal of Oncology 64, no. 3 (2024): 23. https://doi.org/10.3892/ijo.2024.5611